Spinal Nerve Articles & Analysis
24 news found
It contains 3 cases each of frontal lobe, apical lobe, occipital lobe, temporal lobe, midbrain, pons, medulla oblongata, thalamus opticus, cerebellum, hippocampus, callositas, optic nerves, and spinal cord tissue, and 1 case of caudate nucleus. Each case has duplicate cores for each block. ...
January’s Journal of Neurosurgery (JNS) published a series of 17 videos that examine the application of exoscopic visualization in cerebrovascular, neuro-oncologic, pediatric, peripheral nerve, and spinal neurosurgery. The video series highlights the exoscope as a versatile alternative to traditional optical microcopy. ...
The group not only investigates the fundamental scientific issues, such as cell interactions with micro and nano-environments, biomaterials science, and biomechanics, but also solves the technological and translational issues associated with tissue/organ repair and regeneration.? Bioprinted heart, liver, nerve, spinal cord, and brain tumor tissues have been ...
ByCELLINK
But pain elimination comes with a total lack of feeling in the lower body, due to the blocking of spinal nerves. Epidurals still allow for the pushing required of the second stage of labor, so spinal blocks are often used in conjunction with C-sections, though the amount of pain medication may need to be reduced to provide enough feeling for ...
A medial branch block is similar to a nerve block, except that the medication used is injected outside of the joint and closer to the nerves. ...
Overall, dexmedetomidine hydrochloride can be used for general anaesthesia, local anaesthesia, spinal anaesthesia, and nerve-blocking anaesthesia in clinical operations. ...
Included in this type of anesthetic are epidurals and spinal blocks. In some cases patients need to be sedated or calmed through the administration of other drugs. ...
September is National Spinal Cord Injury (SCI) Awareness Month. With over 17,000 new spinal cord injuries taking place every year in the U.S., there is a significant need to call attention to the severity of spinal cord injuries and for continued research to aid in finding a cure. ...
I believe Nalu’s unique system and technology, including the miniaturized, battery-free implantable pulse generator with its broad capabilities, upgradability and industry leading longevity are going to meaningfully expand the number of chronic pain patients who can benefit from both Spinal Cord and Peripheral Nerve Stimulation. Nalu is poised for rapid ...
The Evoke System is the first and only available SCS system capable of instantaneously reading, recording, and responding to evoked compound action potentials (ECAPs) – the nerves’ response to stimulation – to provide precise, continually optimized therapy. ...
This update adds significant new capabilities for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). ...
The Nalu neurostimulation system is currently FDA-cleared for Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) indications. ...
The Nalu neurostimulation system is currently FDA-cleared for Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) ...
The small size of the mIPG translates into a less invasive procedure with the potential to reduce certain post-implant complications associated with larger incisions to accommodate traditional sized IPGs or battery replacement surgeries associated with IPGs containing implantable batteries. Cleared for the spinal cord stimulation and peripheral nerve stimulation ...
(“Nalu”), a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the management of intractable chronic pain for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) indications, launches its ‘Engineered to be More’ branding campaign. ...
Oral presentations include: Novel SCS Waveform Produces Significant Improvements and High Responders (AUS nPower™ study) Session: Spinal Cord Stimulation Waveform and Energy Profile Presenter: Peter Staats, MD, MBA1 When: Friday, July 16, 7:30 am – 7:40 am (EDT) Comfort and Compliance with an External Wearable Component of a Novel, Battery-Free, ...
“We believe our technology design provides a valuable neuromodulation option among the existing spinal cord and peripheral nerve stimulation systems,” said Earl Fender, President and CEO of Nalu Medical, Inc. ...
(“Nalu”), a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the treatment of intractable chronic pain via Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS), announced the release of their latest software upgrade that adds new capabilities to their micro neurostimulation system. ...
Alume Biosciences, Inc., a clinical stage biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead compound ALM-488. ALM-488 is an investigational fluorescently labelled nerve targeting pharmaceutical being developed as an adjunct for the ...
In patients with these antibodies, NMOSD occurs when the complement system—a part of the body’s immune system—over-responds—leading the body to primarily attack the optic nerves and/or spinal cord in the CNS. People living with NMOSD often experience unpredictable attacks, also referred to as relapses, which tend to be severe and recurrent ...